DaVita Inc. Share Price

DaVita Inc. Share Price

NYSE: DVA | Large Cap
$187.63
-$5.17 (-2.68%) Last updated on 31 Oct, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

DaVita Inc. Stock Performance

Open
$174.33
Prev. Close
$192.81
Circuit Range
N/A
Day Range
$174.33 - $187.72
Year Range
$101.06 - $247.15
Volume
1,03,465
Average Traded
$183.29

DaVita Inc. Share Price Today

As of 1 November 2026, DaVita Inc.'s share price is $187.63. The stock opened at $174.33, compared to its previous close of $192.81. During today's trading session, DaVita Inc.'s share price traded between $174.33 and $187.72, with an average price of $181.03. Over the past 52 weeks, the stock has recorded a high of $247.15 and a low of $101.06. In terms of performance, DaVita Inc.'s share price has risen by 21.16% over the last six months and is up 57.70% on a year-on-year basis.

DaVita Inc. Share Price Chart

Line chart of the DaVita Inc. price trend over the selected period. The price fell overall, ranging from 177.99 to 187.63, ending at 187.63.
$174.33$187.72
L
Show Current Price
H

DaVita Inc. Stock Fundamentals & Key Indicators

Market Cap
$13.93B
PE Ratio (TTM)
12.82
Dividend Yield
0.00%
EPS (TTM)
$14.63
Revenue (TTM)
$13.64B
Return On Equity (TTM)
-155.66%
Profit Margin
5.50%
Debt to Equity
-18.22
Quarterly Earnings Growth YoY
-4.82%

DaVita Inc. Quarterly Profit & Loss

All figures in USD

ParticularsDec 2025Mar 2026Jun 2026Sep 2026
Revenue$3619.79$3272.80$3366.38$3408.27
Net Profit$234.22$197.53$265.40$222.93
Net Profit Margin6.47%6.04%7.88%6.54%
Income ChangeN/A-15.66%34.36%-16.00%

DaVita Inc. Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$11.18$12.14$12.82$13.64
Net Profit$0.56$0.69$0.94$0.75
Net Profit Margin5.01%5.68%7.33%5.50%
Income ChangeN/A23.21%36.23%-20.21%

About DaVita Inc.

DaVita is one of the largest providers of dialysis services in the United States, boasting a market share of about 35%. The firm operates over 3,200 facilities worldwide, mostly in the US, and treats about 300,000 patients annually. Government payers dominate US dialysis reimbursement. DaVita receives about two-thirds of US sales at government (primarily Medicare) reimbursement rates, with the remainder coming from commercial insurers. While commercial insurers represent only about 10% of US patients treated, they represent nearly all of the profits generated by DaVita in the US dialysis business.

DaVita Inc. Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Oct 2026
$175.38
$187.34
+6.97%
Sep 2026
$178.18
$175.13
-2.04%
Aug 2026
$241.48
$178.78
-25.52%
Jul 2026
$221.37
$240.04
+7.84%
Jun 2026
$192.72
$222.60
+14.50%
May 2026
$155.43
$194.41
+25.53%
Apr 2026
$152.46
$154.87
+0.73%
Mar 2026
$156.13
$153.75
-1.64%
Feb 2026
$108.95
$156.32
+43.16%
Jan 2026
$113.51
$109.19
-3.90%
Dec 2025
$119.25
$113.63
-5.04%
Nov 2025
$117.40
$119.67
+0.58%

DVA Share Price FAQs